Hancom Lifecare Inc. (KRX:372910)
South Korea flag South Korea · Delayed Price · Currency is KRW
2,065.00
+163.00 (8.57%)
Last updated: Sep 15, 2026, 3:00 PM KST

Hancom Lifecare Income Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
119,41492,088104,776112,780100,120121,140
Other Revenue
--0---0-
119,41492,088104,776112,780100,120121,140
Revenue Growth
34.79%-12.11%-7.10%12.64%-17.35%-20.22%
Cost of Revenue
92,91470,91675,87589,33280,47893,418
Gross Profit
26,49921,17328,90223,44819,64227,722
Selling, General & Admin
21,01420,04619,48119,40318,63420,480
Research & Development
316.2267.09234.02440.61798.4530.5
Amortization of Goodwill & Intangibles
423.21447.56437.01459.96561.22606.56
Other Operating Expenses
315.22348.65354.32364.49412.76239.3
Operating Expenses
28,75127,75021,48521,61621,06522,942
Operating Income
-2,251-6,5787,4161,832-1,4234,781
Interest Expense
-15.1-25.59-31.45-182.08-131.58-468.74
Interest & Investment Income
444.11533.18478.1650.33736.56104.71
Currency Exchange Gain (Loss)
1,922177.21,207256.32-142.03788.62
Other Non Operating Income (Expenses)
-246.01-2,719-70.69-382.05-914.27-904.66
EBT Excluding Unusual Items
-146.4-8,6129,0002,175-1,8744,301
Gain (Loss) on Sale of Investments
892.82118.648.875.3323,920-39.44
Gain (Loss) on Sale of Assets
-374.92-359.0373.98157.83-18.341,333
Asset Writedown
-521.58-521.58--713.2-8,791-
Pretax Income
-150.08-9,3749,0821,62513,2365,594
Income Tax Expense
169.67-1,7081,747753.43,966759.05
Earnings From Continuing Operations
-319.75-7,6667,336871.129,2694,835
Minority Interest in Earnings
-86.62-59.4338.76-46.41-65.47-
Net Income
-406.36-7,7257,375824.719,2044,835
Net Income to Common
-406.36-7,7257,375824.719,2044,835
Net Income Growth
--794.20%-91.04%90.36%-82.54%
Shares Outstanding (Basic)
282828282825
Shares Outstanding (Diluted)
282828282825
Shares Change
----12.31%-1.17%
EPS (Basic)
-14.68-279.14266.4829.80332.58196.22
EPS (Diluted)
-15.00-279.14266.0029.80332.58196.00
EPS Growth
--792.60%-91.04%69.68%-84.94%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
15,13616,96218,164-13,550-681.6318,826
Free Cash Flow Per Share
546.94612.90656.33-489.62-24.63764.02
Gross Margin
22.19%22.99%27.58%20.79%19.62%22.88%
Operating Margin
-1.88%-7.14%7.08%1.62%-1.42%3.95%
Profit Margin
-0.34%-8.39%7.04%0.73%9.19%3.99%
Free Cash Flow Margin
12.68%18.42%17.34%-12.01%-0.68%15.54%
EBITDA
2,317-1,79713,0208,9165,80012,611
EBITDA Margin
1.94%-1.95%12.43%7.91%5.79%10.41%
D&A For EBITDA
4,5694,7815,6047,0847,2237,831
EBIT
-2,251-6,5787,4161,832-1,4234,781
EBIT Margin
-1.88%-7.14%7.08%1.62%-1.42%3.95%
Effective Tax Rate
--19.23%46.38%29.97%13.57%
Advertising Expenses
-511.69706.96764.061,094865.79